In addition, IgG1 sialylation was only lower in the patients with a hematological malignancy pre-HSCT (6.8%) as compared to their donors (9.6%, p = 3.1*10 −4 ), and showed an increasing trend after HSCT (Figure 5 B).
← all excerpts
Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles.
1
—
—